Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period89

File Visits

Downloads
35543-24.pdf60

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period53

Number of downloads in the range

Downloads
35543-24.pdf15

Views

Views
January 20252
February 20254
March 202518
April 202523
May 20252
June 20252
July 20252
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2025
    5
  • February 2025
    0
  • March 2025
    0
  • April 2025
    3
  • May 2025
    1
  • June 2025
    6
  • July 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States21
Singapore18
Hong Kong10
United Kingdom2
Brazil1
South Africa1
 

Top countries by downloads

Downloads
United States3
Hong Kong2
 

Top cities views

Views
The Dalles11
Hong Kong10
Columbus1
Council Bluffs1
Johannesburg1
Marituba1
 

Top cities by downloads

Downloads
Hong Kong2